Autopsy report · NCT01367990
Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
Cause of deathStaffing, sites or logistics
“Study site has terminated the study due to the complexity of the study”
Life of this trial
- Registered 1 month before it started.
- Ran for about 9 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- ProCertus BioPharm, Inc
- Sponsor type
- Industry
- Conditions
- Alopecia; Radiodermatitis
- Interventions
- Norepinephrine
- Participants
- 3
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Thoracic Kyphosis and Osteoporosis: Study of Their Relationship With Respiratory Functions in Chronic Obstructive Pulmonary Disease.
“The site is no more able to conduct the study” - Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
“The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned” - CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
“Study terminated due to slow/insufficient accrual.” - Randomized Controlled Study to Incentivize Doctors for Appropriate Use of Medical Care in NL
“The study was terminated due to logistical reasons” - LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
“Study was terminated due to slow accrual.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.